Brain N-acetyl aspartate concentrations measured by 1H MRS are reduced in adult male rats subjected to perinatal stress: Preliminary observations and hypothetical implications for neurodevelopmental disorders

Journal of Psychiatric Research

Volumn 33, Issue 1, 1999, Pages 41-51

  Poland, Russell E ^a,b   Cloak, Christine ^a   Lutchmansingh, Preetam J ^a   McCracken, James T ^b   Chang, Linda ^a   Ernst, Thomas ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Depression; Perinatal stress; Proton magnetic resonance spectroscopy (1H MRS); Schizophrenia

Indexed keywords

N ACETYLASPARTIC ACID;

ANIMAL EXPERIMENT; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; IMMOBILIZATION STRESS; NEUROPATHOLOGY; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; STRESS;

EID: 0032921984     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(98)00043-0     Document Type: Article

References (135)

1. Akbarian S, Viñuela A, Kim JJ, Potkin SG, Bunney Jr. WE, Jones EG. Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Arch Gen Psychiatry 1993;50:178-187.
2. Alonso E, García-Pérez MA, Bueso J, Rubio V. N-Acetyl-L-glutamate in brain: assay, levels, and regional and subcellular distribution. Neurochem Res 1991;16:787-794.
3. Alonso SJ, Navarro E, Rodriguez M. Permanent dopaminergic alterations in the N. accumbens after prenatal stress. Pharmacol Biochem Behav 1994;49:353-358.
4. Arus C, Chang Y, Bárány M. Proton nuclear magnetic resonance spectra of excised rat brain, assignment of resonances. Physiol Chem Phys Med NMR 1985;17:23-33.
5. Ashwal S, Holshouser BA, Hinshaw DB, Schell RM, Bailey L. Proton magnetic resonance spectroscopy in the evaluation of children with congenital heart disease and acute central nervous system injury. J Thoracic Cardiovasc Surg 1996;112:403-414.
6. Bakker JM, Schmidt ED, Kroes H, Kavelaars A, Heijnen CJ, Tilders FJ, van Rees EP. Effects of short-term dexamethasone treatment during pregnancy on the development of the immune system and the hypothalamo-pituitary adrenal axis in the rat. J Neuroimmunol 1995;63:183-191.
7. Bartha R, Williamson PC, Drost DJ, Malla A, Carr TJ, Cortese L, Canaran G, Rylett RJ, Neufeld RW. Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 1997;54:959-965.
8. Benes FM. The role of stress and dopamine-GABA interactions in the vulnerability for schizophrenia. J Psychiatric Res 1997;31:257-275.
9. Bertolino A, Nawroz S, Mattay VS, Barnett AS, Duyn JH, Moonen CTW, Frank JA, Tedeschi G, Weinberger DR. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am J Psychiatry 1996;153:1554-1563.
10. Bertolino A, Saunders RC, Mattay VS, Bachevalier J, Frank JA, Weinberger DR. Altered development of prefrontal neurons in rhesus monkeys with neonatal mesial temporo-limbic lesions: a proton magnetic resonance spectroscopic imaging study. Cerebral Cortex 1997;7:740-748.
11. 1H-MRS in patients with schizophrenia. Neuropsychopharmacology 1998;18:1-9.
12. Bertolino A, Callicott JH, Elman I, Mattay VS, Gedeschi G, Frank JA, Breier AS, Weinberger DR. Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study. Biol Psychiatry 1998;43:641-648.
13. 1H-NMR spectroscopic studies of brain. Neurosci Biobehav Rev 1989;13:23-31.
14. Blakely RD, Coyle JT. The neurobiology of N-acetylaspartyglutamate. Int Rev Neurobiol 1988;30:39-100.
15. Bloom FE. Advancing a neurodevelopmental origin for schizophrenia. Arch Gen Psychiatry 1993;50:224-227.
16. Brixey SN, Gallagher BJ, McFalls Jr. JA, Ferraro-Parmalee L. Gestational and neonatal factors in the etiology of schizophrenia. J Clin Psychol 1993;49:447-456.
17. Brooks WM, Hodde-Vargas J, Vargas LA, Yeo RA, Ford CC, Hendren RL. Frontal lobe of children with schizophrenia spectrum disorders: a proton magnetic resonance spectroscopic study. Biol Psychiatry 1998;43:263-269.
18. Brown AS, Susser ES, Lin SP, Neugebauer R, Gorman JM. Increased risk of affective disorders in males after second trimester prenatal exposure to the Dutch Hunger Winter of 1944-1945. Br J Psychiatry 1995;166:601-606.
19. Brown AS, Susser ES, Butler PD, Andrews RR, Kaufmann CA, Gorman JM. Neurobiological plausibility of prenatal nutritional deprivation as a risk factor for schizophrenia. J Nervous Mental Dis 1996;184:71-85.
20. 1H-Magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: clinical, neurodevelopmental, and cognitive correlates. Biol Psychiatry 1994;36:792-800.
21. 1H magnetic resonance spectroscopy of rat brain extracts compared with chromatographic methods. Neurochem Res 1990;15:1009-1016.
22. Butler PD, Susser ES, Brown AS, Kaufmann CA, Gorman JM. Prenatal nutritional deprivation as a risk factor in schizophrenia: preclinical evidence. Neuropsychopharmacology 1994;11:227-235.
23. Cabib S, Puglisi-Allegra S. Stress, depression and the mesolimbic dopamine system. Psychopharmacology 1997;4:331-343.
24. 1H-MRS study. 1st Symposium on Magnetic Resonance Applied to Psychiatry (abstract). Rouffach, France, 1994. p. 52.
25. Chang L, Yener GG, Miller BL, Mehringer M. Magnetic resonance spectroscopy and single photon emission computed tomography in Alzheimer's Disease: new directions. Facts Res Gerontol 1994;5:67-78.
26. 1H MRS in HIV and HIV-related brain diseases. Rev Neurosci 1995;6:365-378.
27. Chang L, Mehringer CM, Ernst T, Melchor R, Myers H, Forney D, Satz P. Neurochemical alterations in asymptomatic abstinent cocaine users: a proton magnetic resonance spectroscopy study. Biol Psychiatry 1997;42:1105-1114.
28. Chang L, Ernst T, Osborn D, Seltzer W, Leonido-Yee M, Poland RE. Proton spectroscopy in myotonic dystrophy: correlations with CTG repeats. Arch Neurol 1998;55:305-311.
29. Charles HC, Lazeyras F, Boyko O, Allen A, Krishnan KRR. Elevated choline concentrations in basal ganglia of depressed patients. Biol Psychiatry 1992;31:991 (Abstract).
30. Charles HC, Lazeyras F, Krishnan KRR, Boyko OB, Payne M, Moore D. Brain choline in depression: in vivo detection of potential pharmacodynamic effects of antidepressant therapy using hydrogen localized spectroscopy. Prog Neuro-Psychopharmacol Biol Psychiatry 1994;18:1121-1127.
31. Choe B-Y, Suh T-S, Shinn K-S, Lee C-W, Lee C, Paik I-H. Observation of metabolic changes in chronic schizophrenia after neuroleptic treatment by in vivo hydrogen magnetic resonance spectroscopy. Invest Radiol 1996;31:345-352.
32. Clarke AS, Schneider ML. Prenatal stress has long-term effects on behavioral responses to stress in juvenile rhesus monkeys. Devel Psychobiol 1993;26:293-304.
33. Coplan JD, Andrews MW, Rosenblum LA, Owens MJ, Friedman S, Gorman JM, Nemeroff CB. Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: implications for the pathophysiology of mood and anxiety disorders. Proc Natl Acad Sci USA 1996;93:1619-1623.
34. Cross AJ, Crow TJ, Owen F. Gamma-aminobutyric acid in the brain in schizophrenia. Lancet 1979;1:560-561.
35. Deicken RF, Zhou L, Corwin MA, Vinogradov S, Weiner MW. Decreased left frontal lobe N-acetylaspartate in schizophrenia. Am J Psychiatry 1997;154:688-690.
36. 1H-MRS. Biol Psychiatry 1998;43:483-488.
37. Elman I, Adler CM, Malhotra AK, Bir C, Pickar D, Breier A. Effects of acute metabolic stress on pituitary-adrenal axis activation in patients with schizophrenia. Am J Psychiatry 1998;155:979-981.
38. Fameli M, Kitraki E, Stylianopoulou F. Effects of hyperactivity of the maternal hypothalamic-pituitary-adrenal (HPA) axis during pregnancy on the development of the HPA axis and brain monoamines of the offspring. Int J Devel Neurosci 1994;12:651-659.
39. Federico F, Simone IL, Lucierero V, De Mari M, Giannini P, Iliceto G, Mazzapesa D, Lamberti P. Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1997;62:239-242.
40. Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?. J Psychiatric Res 1982;17:319-334.
41. Feldon J, Weiner I. Long-term attentional deficit in nonhandled males: possible involvement of the dopaminergic system. Psychopharmacology 1988;95:231-236.
42. Feldon J, Avnimelech-Gigus N, Weiner I. The effects of pre-and post-weaning rearing conditions on latent inhibition and partial reinforcement extinction effect in male rats. Behav Neural Biol 1990;53:189-204.
43. Felszeghy K, Gaspar E, Nyakas C. Long-term selective down-regulation of brain glucocorticoid receptors after neonatal dexamethasone treatment in rats. J Neuroendocrinol 1996;8:493-499.
44. 1H NMR spectra of human brain in vivo. NMR Biomed 1991;4:201-204.
45. Fride E, Dan Y, Feldon J, Halevy G, Weinstock M. Effects of prenatal stress on vulnerability to stress in prepubertal and adult rats. Physiol Behav 1986;37:681-687.
46. Fujimoto T, Nakano T, Takano T, Takeuchi K, Yamada K, Fukuzako T, Akimoto H. Proton magnetic resonance spectroscopy of basal ganglia in chronic schizophrenia. Biol Psychiatry 1996;40:14-18.
47. Fukuzako H, Takeuchi K, Hokazono Y, Fukzako T, Yamada K, Hashiguchi T, Obo Y, Ueyama K, Takigawa M, Fujimoto T. Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: preliminary report. Psychiatry Res Neuroimaging 1995;61:193-200.
48. Giroud M, Walker P, Bernard D, Lemesle M, Didier M, Baudouin N, Brunotte F, Dumas R. Reduced brain N-acetyl-aspartate in frontal lobes suggests neuronal loss in patients with amyotrophic lateral sclerosis. Neurol Res 1996;18:241-243.
49. Goldman M, Tandon R, Taylor SF, DeQuardo JR, Shipley JE, Patel B, Reddig S, Jibson M. Dexamethasone nonsuppression and short rapid eye movement latency in schizophrenia: markers of an affective diathesis?. Biol Psychiatry 1996;40:927-929.
50. Gray JA, Joseph MH, Hemsley DR, Young AMJ, Warburton EC, Boulenguez P, Grigoryan GA, Peters SL, Rawlins JNP, Tai CT, Yee BK, Cassaday HJ, Weiner I, Gal G, Gusak O, Joel D, Shadrach E, Shalev U, Tarrash R, Feldon J. The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: implications for schizophrenia. Behav Brain Res 1995;71:19-31.
51. Haigh JR, McCracken JT, Poland RE. Effect of prenatal stress on 5-HT indices in adult rat frontal cortex. Society of Neuroscience Abstracts, 26th Annual Meeting, Washington DC, vol. 22, part 3, Nov. 16-21, 1996. p. 2058.
52. Hamakawa H, Kato T, Murashita J, Kato N. Quantitative magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders. Eur Arch Psychiatry Clin Neurosci 1998;248:53-58.
53. Harms L, Meierkord H, Timm G, Pfeiffer L, Ludolph AC. Decreased N-acetyl-aspartate/choline ratio and increased lactate in the frontal lobe of patients with Huntington's disease: a proton magnetic resonance spectroscopy study. J Neurol Neurosurg Psychiatry 1997;62:27-30.
54. 1H-NMR spectroscopy. J Neurochem 1997;68:305-312.
55. Henry C, Kabbaj M, Simon H, Le Moal M, Maccari S. Prenatal stress increases the hypothalamo-pituitary adrenal axis response in young and adult rats. J Neuroendocrinol 1994;6:341-345.
56. 1H MRS in the evaluation of Huntington's and Parkinson's diseases. Neurology 1998;50:1033-1040.
57. Holsboer F. Neuroendocrinology of mood disorders. In: Bloom F, Kupfer DJ, editors. Psychopharmacology: the fourth generation of progress. New York: Raven Press, 1995. p. 957-69.
58. Hutchings DE, editor. Prenatal abuse of licit and illicit drugs. Ann N Y Acad Sci 1989;562.
59. Insel TR. Decreased in vivo binding to brain benzodiazepine receptors during social isolation. Psychopharmacology 1989;97:142-144.
60. Johnston MV. Neurotransmitters and vulnerability of the developing brain. Brain Devel 1995;17:301-306.
61. Kato T, Hamakawa H, Shioiri T, Murashita J, Takahashi Y, Takahashi S, Inubushi T. Choline-containing compounds detected by proton magnetic resonance spectroscopy in the basal ganglia in bipolar disorder. J Psychiatry Neurosci 1996;21:248-254.
62. Kehoe P, Hoffman JH, Austin-LaFrance RJ, Bronzino JD. Neonatal isolation enhances hippocampal dentate response to tetanization in freely moving juvenile male rats. Exp Neurol 1995;136:89-97.
63. Keshavan MS, Anderson S, Pettegrew JW. Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. J Psychiatric Res 1994;28:239-265.
64. Keshavan MS, Montrose DM, Pierri JN, Dick EL, Rosenberg D, Talagala L, Sweeney JA. Magnetic resonance imaging and spectroscopy in offspring at risk for schizophrenia: preliminary studies. Prog Neuro-Psychopharmacol Psychiatry 1997;21:285-1295.
65. 31P MRS of PCA extracts of postmortem Alzheimer's disease brain. Neurobiol Aging 1996;17:349-357.
66. 1H-NMR spectroscopy study of schizophrenics. In: Society of Magnetic Resonance Book of Abstracts. Berkeley, California, SMR, 1995. p. 1846.
67. Kreis R, Ernst T, Ross BD. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 1993;30:424-437.
68. Ladd CO, Owens MJ, Nemeroff CB. Persistent changes in CRF neuronal systems induced by maternal deprivation. Endocrinology 1996;137:1212-1218.
69. Lafer B, Renshaw PF, Sachs G, Christensen JD, Yurgelun-Todd D, Stoll AL, Rosenbaum JF, Cohen BM. Proton MRS of the basal ganglia in bipolar disorder. Biol Psychiatry 1994;35:685 (Abstract).
70. Lammers CH, Garcia-Borreguero D, Schmider J, Gotthardt U, Dettling M, Holsboer F, Heuser IJ. Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls. Biol Psychiatry 1995;38:803-807.
71. Levitt JJ, Tsuang MT. The heterogeneity of schizoaffective disorder. Am J Psychiatry 1988;145:926-936.
72. Lillrank SM, Lipska BK, Weinberger DR. Neurodevelopmental animal models of schizophrenia. Clin Neurosci 1995;3:98-104.
73. Liu D, Diorio J, Tannenbaum B, Caldji C, Francis D, Freedman A, Sharma S, Pearson D, Plotsky PM, Meaney MJ. Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. Science 1997;277:1659-1662.
74. Lou HC, Hansen D, Nordentoft M, Pryds O, Jensen F, Nim J, Hemmingsen R. Prenatal stressors of human life affect fetal brain development. Devel Med Child Neurol 1994;36:826-832.
75. Maccari S, Piazza PV, Kabbaj M, Barbazanges A, Simon H, Le Moal M. Adoption reverses the long-term impairment in glucocorticoid feedback induced by prenatal stress. J Neurosci 1995;15 (Part 1):110-116.
76. Maier M, Ron MA, Barker GJ, Tofts PS. Proton magnetic resonance spectroscopy: an in vivo method of estimating hippocampal neuronal depletion in schizophrenia. Psychol Med 1995;25:1201-1209.
77. McGivern RF, Poland RE, Taylor AN, Branch BJ, Raum WJ. Prenatal stress feminizes adult male saccharin preference and maze learning: antagonism by propranolol. In: Dorner G, McCann SM, editors. Systemic hormones, neurotransmitters and brain development, vol. 12. Basel: Karger, 1986. p. 172-8.
78. Meaney MJ, Aitken DH, Viau V, Sharma S, Sarrieau A. Neonatal handling alters adrenocortical negative feedback sensitivity and hippocampal type II glucocorticoid receptor binding in the rat. Neuroendocrinology 1989;50:597-604.
79. Mehta V, Namboodiri MAA. N-Acetylaspartate as an acetyl source in the nervous system. Mol Brain Res 1995;31:151-157.
80. 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 1991;4:47-52.
81. 1H MR spectrum of patients with probable Alzheimer disease. Magn Reson Med 1994;31:110-115.
82. Moore CM, Redmond OM, Buckley P, Larkin C, Stack JP, Waddington J, Ennis JT. In vivo proton NMR spectroscopy (STEAM) in patients with schizophrenia. Proc Soc Reson Med 1992;11:1933.
83. Nadler JV, Cooper JR. N-Acetyl-L-aspartic acid content of human neural tumors and bovine peripheral nervous tissues. J Neurochem 1982;19:313-319.
84. 1H MRS) of the hippocampal formation in schizophrenia: a pilot study. Br J Psychiatry 1994;165:481-485.
85. 1H-MRS of postmortem brain with schizophrenia. Biol Psychiatry 1997;42:359-366.
86. 1H-MRS can differentiate Alzheimer's disease from normal aging. Mech Ageing Develop 1997;97:9-14.
87. Peden CJ. Proton spectroscopy of the neonatal brain following hypoxic-ischaemic injury. Devel Med Child Neurol 1993;35:502-510.
88. Perry TL, Kish SJ, Buchanan J, Hansen S. Gamma-aminobutyric-acid deficiency in brain of schizophrenic patients. Lancet 1979;1:237-239.
89. Peters DA. Effects of maternal stress during different gestational periods on the serotonergic system in adult rat offspring. Pharmacol Biochem Behav 1989;31:839-843.
90. 31P nuclear magnetic resonance spectroscopy: neurodevelopment and schizophrenia. Schizophrenia Bull 1993;19:35-53.
91. Plotsky PM, Meaney MJ. Early postnatal experience alters hypothalamic corticotropin-releasing factor (CRF) mRNA, median eminence CRF content and stress-induced release in adult rats. Mol Brain Res 1993;18:195-200.
92. Poland RE, Rubin RT, Weichsel Jr. ME. Circadian patterns of rat anterior pituitary and target gland hormones in serum: determination of the appropriate sample size by statistical power analysis. Psychoneuroendocrinology 1980;5:209-224.
93. Poland RE, Lutchmansingh P, Au D, Edelstein M, Lydecker S, Hsieh C, McCracken JT. Exposure to threshold doses in nicotine in utero: I. Neuroendocrine response to restraint stress in adult male offspring. Life Sci 1994;55:1567-1575.
94. Poland RE, Lutchmansingh P, Au D, Hsieh C, Acosta S, Lydecker S, McCracken JT. Exposure to threshold doses in nicotine in utero: II. Neuroendocrine response to nicotine in adult male offspring. Devel Brain Res 1994;83:278-284.
95. Poland RE, Lutchmansingh P, McGeoy S, Au D, Que M, Acosta S, Edelstein M, McCracken JT. Prenatal stress prevents the desensitization of the corticosterone response to TFMPP by desmethylimipramine, but not by phenelzine, in adult male offspring. Life Sci 1995;57:2163-2170.
96. Poland RE, Lutchmansingh P, Au D, McGeoy S, Que M, Acosta S, McCracken JT. Exposure to threshold doses of nicotine in utero: III. Augmentation of the prolactin and ACTH response to 8-OH DPAT by desipramine treatment is compromised in adult male offspring. NeuroToxicology 1996;17:351-358.
97. Rajkowska G, Selemon LD, Goldman-Rakic PS. Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch Gen Psychiatry 1998;55:215-224.
98. 1H MRS abnormalities in depressed patients suggest impaired second messenger cycling. Biol Psychiatry 1993;33:441 (Abstract).
99. Renshaw PF, Lafer B, Christensen JD, Stoll AL, Rothschild A, Fava M, Rosenbaum JF, Cohen BM. Proton MRS of the basal ganglia in major depression. Biol Psychiatry 1994;35:685 (Abstract).
100. Renshaw PF, Yurgelun-Todd DA, Tohen M, Gruber S, Cohen BM. Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis. Am J Psychiatry 1995;152:444-446.
101. Renshaw PF, Lafer B, Babb SM, Fava M, Stoll AL, Christen JD, Moore CM, Yurgelun-Todd DA, Bonello CM, Pillay SS, Rothschild AJ, Nierenberg AA, Rosenbaum JF, Cohen BM. Basal ganglia choline levels in depression and response to fluoxetine treatment: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 1997;35:837-843.
102. Rosenblum LA, Coplan JD, Friedman S, Bassoff T, Gorman JM, Andrews MW. Adverse early experiences affect noradrenergic and serotonergic functioning in adult primates. Biol Psychiatry 1994;35:221-227.
103. Ross B, Kreis R, Ernst Th. Clinical tools for the 90s. MRS and metabolite imaging. Eur J Radiol 1992;14:128-140.
104. Roth BL, Meltzer HY. The role of serotonin in schizophrenia. In Bloom FE, Kupfer DJ, editors. Psychopharmacology: the fourth generation of progress. New York: Raven Press, 1995. p. 1215-27.
105. Rubin RT, Poland RE, Lesser IM, Winston RA, Blodgett ALN. Neuroendocrine aspects of primary endogenous depression I. Cortisol secretory dynamics in patients and matched controls. Arch Gen Psychiatry 1987;44:328-336.
106. Sager TN, Laursen H, Hansen AJ. Changes in N-acetyl-aspartate content during focal and global brain ischemia of the rat. J Cerebral Blood Flow Metab 1995;15:639-646.
107. Schneider ML, Coe CL, Lubach GR. Endocrine activation mimics the adverse effects of prenatal stress on the neuromotor development of the infant primate. Devel Psychobiol 1992;25:427-439.
108. Sharma R, Venkatasubramanian PN, Barany M, Davis JM. Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients. Schizophrenia Res 1992;8:43-49.
109. Slotkin TA. Fetal nicotine or cocaine exposure: which one is worse?. J Pharmacol Exp Ther 1998;285:931-945.
110. Smith GN, MacEwan GW, Altman S, Meistrich B, Lapointe JS, Kopala L, Honer WG. Obstetric complications and age-related changes in brain morphology in schizophrenia. Biol Psychiatry 1996;40:1200-1208.
111. Soares JC, Krishnan RR, Keshavan MS. Nuclear magnetic resonance spectroscopy: new insights into the pathophysiology of mood disorders. Depression 1996;4:14-30.
112. Stanley JA, Drost DJ, Williamson PC, Carr TJ. In vivo proton MRS study of glutamate and schizophrenia. In Nasrallah HA, Pettegrew JW, editors. NMR spectroscopy in psychiatric brain disorders. Washington, DC: American Psychiatric Association, 1995a. p. 21-44.
113. Stanley JA, Williamson PC, Drost DJ, Carr TJ, Rylett RJ, Malla A, Thompson T. An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy. Arch Gen Psychiatry 1995;52:399-406.
114. Stanley JA, Williamson PC, Drost DJ, Rylett RJ, Carr TJ, Malla A, Thompson RT. An in vivo proton magnetic resonance spectroscopy study of schizophrenia patients. Schizophrenia Bull 1996;22:597-609.
115. Stoll AL, Renshaw PF, Sachs GS, Guimaraes AR, Miller C, Cohen BM, Lafer B, Gonzalez RG. The human brain resonance of choline-containing compounds is similar in patients receiving lithium treatment and controls: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 1992;32:944-949.
116. Susser E, Neugebauer R, Hoek HW, Brown AS, Lin S, Labovitz D, Gorman JM. Schizophrenia after prenatal famine. Further evidence. Arch Gen Psychiatry 1996;53:25-31.
117. Takei N, Mortensen PB, Klaening U, Murray RM, Sham PC, O'Callaghan E, Munk-Jrgensen P. Relationship between in utero exposure to influenza epidemics and risk of schizophrenia in Denmark. Biol Psychiatry 1996;40:817-824.
118. Tsai G, Coyle JT. N-Acetylaspartate in neuropsychiatrie disorders. Prog Neurobiol 1995;46:531-540.
119. Tsai G, Passani LA, Slusher BS, Carter R, Baer L, Kleinman JE, Coyle JT. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry 1995;52:829-836.
120. 1H-MR spectroscopy in childhood-onset schizophrenia. J Magn Reson Imaging 1998;8:841-846.
121. Vaid RR, Yee BK, Shalev U, Rawlins JNP, Weiner I, Feldon J, Totterdell S. Neonatal nonhandling and in utero prenatal stress reduce the density of NADPH-diaphorase-reactive neurons in the fascia dentata and Ammon's horn of rats. J Neurosci 1997;17:5599-5609.
122. Verdoux H, Geddes JR, Takei N, Lawrie SM, Bovet P, Eagles JM, Heun R, McCreadie RG, McNeil TF, O'Callaghan E, Stöber G, Willinger MU, Wright P, Murray RM. Obstetric complications and age at onset in schizophrenia: an international collaborative meta-analysis of individual patient data. Am J Psychiatry 1997;154:1220-1227.
123. Wadhwa PD, Sandman CA, Porto M, Dunkel-Schetter C, Garite TJ. The association between prenatal stress and infant birth weight and gestational age at birth: a prospective investigation. Am J Obstetrics Gynecol 1993;169:858-865.
124. Walker EF, Diforio D. Schizophrenia: a neural diathesis-stress model. Psychol Rev 1997;104:667-685.
125. Wang CT, Huang RL, Tai MY, Tsai YF, Peng MT. Dopamine release in the nucleus accumbens during sexual behavior in prenatally stressed adult male rats. Neurosci Lett 1995;200:29-32.
126. Ward AJ. Prenatal stress and childhood psychopathology. Child Psychiatry Human Devel 1991;22:97-110.
127. Weinberger DR. From neuropathology to neurodevelopment. Lancet 1995;346:552-557.
128. Weinstock M, Fride E, Hertzberg R. Prenatal stress effects on functional development of the offspring. Prog Brain Res 1988;73:319-331.
129. Weinstock M, Matlina E, Maor GI, Rosen H, McEwen BS. Prenatal stress selectively alters the reactivity of the hypothalamic-pituitary adrenal system in the female rat. Brain Res 1992;595:195-200.
130. Weinstock M. Does prenatal stress impair coping and regulation of hypothalamic-pituitary-adrenal axis?. Neurosci Biobehav Rev 1997;21:1-10.
131. Wolf SS, Weinberger DR. Schizophrenia: a new frontier in developmental neurobiology. Israel J Med Sci 1996;32:51-55.
132. Wyatt RJ. Commentary: neurodevelopmental abnormalities and schizophrenia. A family affair. Arch Gen Psychiatry 1996;53:11-15.
133. 1H magnetic resonance spectroscopy (MRS) of the temporal lobes in schizophrenia. Schizophrenia Res 1993;9:213.
134. Yurgelun-Todd DA, Renshaw PF, Gruber SA, Ed M, Waternaux C, Cohen BM. Proton magnetic resonance spectroscopy of the temporal lobes in schizophrenics and normal controls. Schizophrenia Res 1996;19:55-59.
135. Zagon IS, Slotkin TA, editors. Maternal substance abuse and the developing nervous system. San Diego: Academic Press, 1992.